Search Within

Hematologic Malignancies, Division of

Formats
  1. Meeting Abstract (6372)
  2. Journal Article (5769)
  3. Review (420)
  4. Editorial (194)
  5. Book Section (188)
  6. Research Letter (178)
  7. Guidelines (88)
  8. Conference Paper (65)
  9. Correspondence (61)
  10. Miscellaneous (18)
  11. Book Whole (9)
Groups
  1. Department of Medicine (13261)
  2. Center for Hematologic Malignancies (10597)
  3. GSK Faculty (4477)
  4. Adult Leukemia (3668)
  5. Bone Marrow Transplant (2846)
  6. Lymphoma (2702)

More Groups

People
  1. Sergio Giralt (1067)
  2. Miguel-Angel Perales (942)
  3. Ross Levine (786)
  4. Andrew Zelenetz (784)
  5. Steven Horwitz (668)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (323)
  2. 2024 (823)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3528)
  2. Journal of Clinical Oncology (1233)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (329)
  5. Haematologica (291)
  6. Bone Marrow Transplantation (239)

More Publications

Publishers
  1. American Society of Hematology (3803)
  2. Elsevier Inc. (1623)
  3. American Society of Clinical Oncology (1288)
  4. Nature Publishing Group (1008)
  5. American Association for Cancer Research (641)
  6. Wiley Blackwell (433)

More Publishers

Results (13362)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I study of AFNT-211, autologous CD4(+) and CD8(+) T cells engineered to express a high avidity HLA-A(*)11:01-restricted, KRAS G12V-specific transgenic TCR; CD8α/β coreceptor; and FAS-41BB switch receptor in patients with advanced or metastatic solid tumors
    Meeting Abstract

    Basu, S. K.; Khan, B.; Payumo, F.; Wan, R.; Chiorean, E. G.; Gahvari, Z.; Hecht, J. R.; Hurwitz, M. E.; Leidner, R. S.; Lenz, H. J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A phase 1, first-in-human study of CTIM-76, a claudin-6 (CLDN6)-directed bispecific antibody, in patients with recurrent ovarian cancer and other advanced solid tumors
    Meeting Abstract

    O'Cearbhaill, R. E.; Barve, M. A.; Darus, C.; Gabrail, N. Y.; Johannet, P.; Loh, J.; Lerose, M.; Andreas, K.; Ullmann, C. D.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A phase 1, first-in-human study of DS-2243, an HLA-A(*)02/NY-ESO-directed bispecific T-cell engager, in patients with advanced solid tumors
    Meeting Abstract

    D'Angelo, S. P.; Subbiah, V.; Blay, J. Y.; Wagner, M. J.; Steeghs, N.; Youk, J.; Mizusako, H.; Ohue, Y.; Jin, J.; Rajper, A. W.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A phase 1/2 study evaluating the safety and efficacy of autologous TAC T cells in subjects with claudin 18.2(+)advanced solid tumors
    Meeting Abstract

    Sohal, D.; Iqbal, S.; Turcotte, S.; Botta, G. P.; Schlechter, B. L.; Ku, G. Y.; Hosein, P. J.; Saibil, S.; Gavriliuc, M.; Apostolopoulou, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Pneumocystis jirovecii pneumonia with use of brentuximab vedotin in treatment-naïve Hodgkin lymphoma
    Correspondence

    Gurumurthi, A.; Henshaw, L.; Falchi, L.; Moskowitz, A.; Noy, A.; Seo, S.; Stuver, R.
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: Insights from a retrospective analysis
    Journal Article

    Luttwak, E.; Robin, E. T.; Drill, E.; Boardman, A.; Caron, P.; Epstein-Peterson, Z.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • ASTCT and USCLC clinical practice recommendations for allogeneic stem cell transplant in mycosis fungoides and Sézary syndrome
    Guidelines

    Goyal, A.; O'Leary, D.; Dabaja, B.; Weng, W. K.; Zain, J.; Cutler, C.; Guitart, J.; Kim, Y. H.; Geskin, L. J.; Hoppe, R. T.; more...
    Journal of the American Academy of Dermatology (2025)

    Fulltext@MSK | Save
  • Long-term (≥5-year) remission and survival after treatment with ciltacabtagene autoleucel in CARTITUDE-1 patients with relapsed/refractory multiple myeloma
    Journal Article

    Jagannath, S.; Martin, T. G.; Lin, Y.; Cohen, A. D.; Raje, N.; Htut, M.; Deol, A.; Agha, M.; Berdeja, J. G.; Lesokhin, A. M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Treatment patterns and real-world outcomes of molecular subgroups in patients with AML receiving frontline venetoclax-based therapy
    Journal Article

    Lachowiez, C. A.; Barcellos, A.; Zettler, C. M.; Belli, A. J.; Fernandes, L. L.; Hansen, E.; Wang, C. K.; Owusu, H. F.; Zeidan, A. M.; Stein, E. M.; more...
    JCO Oncology Practice (2025)

    Fulltext@MSK | Save
  • Characterization of belantamab mafodotin-induced corneal changes in patients with multiple myeloma
    Journal Article

    Lee, V.; Hultcrantz, M.; Petrone, S.; Lewis, E. W.; Banna, H.; Lichtman, E.; Thulasi, P.; Quick, A. A.; Jeng, B. H.; Sunshine, S. B.; more...
    JAMA Ophthalmology (2025)

    Fulltext@MSK | Save